Tax Reform and Pharmaceuticals

Mar 9, 2018

The pharmaceutical industry is being prompted to take advantage of tax-reform and produce more drugs.

This article discusses why top companies have money to spend, and the importance of research and development.

To view this article, click the following link to access the original content.

https://www.forbes.com/sites/stanfleming/2018/02/15/how-pharma-can-minimize-political-risk-from-its-repatriation-windfall/#23678463640f

Blackman & Sloop is the brand name under which Blackman & Sloop Advisors, Inc. provides professional services. Blackman & Sloop Advisors, Inc. and Balance & Strategy Advisors, CPA’s LLP practice as an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations and professional standards. Balance & Strategy Advisors, CPA’s LLP is a licensed independent CPA firm that provides attest services to its clients. Blackman & Sloop Advisors, Inc. and its subsidiary entities, which are not licensed CPA firms, provide tax, advisory, and other non-attest services to its clients. The entities are independently owned and are not liable for the services provided by any other entity providing the services under the Blackman & Sloop brand. Our use of the terms "our firm" and "we" and "us" and terms of similar import, denote the alternative practice structure conducted by Balance & Strategy Advisors, CPA’s LLP and Blackman & Sloop Advisors, Inc.